IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1780
-0.0113 (-5.97%)
At close: Apr 28, 2025, 4:00 PM
0.1760
-0.0020 (-1.12%)
Pre-market: Apr 29, 2025, 4:01 AM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $14.46 million as of April 28, 2025. Its market cap has decreased by -69.62% in one year.
Market Cap
14.46M
Enterprise Value
8.37M
1-Year Change
-69.62%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $14.46M, a decrease of -92.29%. That is a compound annual growth rate of -49.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 15.38M | -17.49% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |